Alurar rigakafin Japanese Encephalitis (JE) alura ce da aka yi don kariya daga cutar kumburi na kwakwalwa (encephalitis) da kwayar cutar JE ke haifarwa. Cutar tana yaduwa ta hanyar cizon sauro na Culex, kuma tana da alaka da gonar shinkafa da alade a yankunan karkara na Asiya. Cutar JE ba ta yaduwa a Nijeriya ko Afirka ta Yamma ba — tana da alaka da yankunan kudancin Asiya da gabashin Asiya musamman. Amma matafiya daga Nijeriya da ke tafiya zuwa wadannan yankunan na iya bukatar alurar. WHO ta
Pregnancy: Limited data — use only if risk is high.
Limited safety data for Ixiaro (inactivated Vero cell vaccine) in pregnancy.
Administer only if the risk of Japanese encephalitis exposure is judged to be high (prolonged rural travel during transmission season in endemic Asia).
No teratogenic effects reported in animal studies.
Live attenuated JE formulations (SA14-14-2, Imojev): contraindicated in pregnancy.
Defer vaccination until after delivery whenever possible.
Breastfeeding: Limited data — likely safe.
No formal studies of Ixiaro during breastfeeding. As an inactivated vaccine, it is unlikely to pose a risk to the breastfed infant. CDC considers inactivated vaccines generally acceptable during breastfeeding.
Pediatric use:
Ixiaro: licensed from 2 months of age.
Booster: 1 dose ≥1 year after primary series if ongoing exposure risk.
Live attenuated SA14-14-2 (in endemic countries): single dose from 8 months of age.
Geriatric use:
No specific dose adjustment required.
Immune response may be slightly lower in elderly adults — consider booster if ongoing exposure risk.
Japanese encephalitis is more severe in older adults (higher case-fatality rate in ≥65 years).
Standard 2-dose Ixiaro schedule applies.
Babu bayanan jadawali.
Kun san allurar rigakafin da kuke bukata? Da kyau. Ba ku sani ba? Ku gaya mana inda kuke tafiya — za mu nemo allurar da ta dace da asibiti. Kyauta, ba tare da wani hakki ba.
Abun ciki a wannan shafin don bayani da ilimi ne kawai. Ba ya zama shawarar likita, gano cuta, ko shawarwarin magani ba. Idan kuna da damuwar lafiya, tuntuɓi ƙwararren ma’aikacin lafiya. Medova ba mai ba da sabis na likitanci ba ne.
Cikakkun sharuɗɗan amfani